Nokia Will Offer Free Netflix to Device Buyers and 2 More Heavily Traded Stocks to Follow

Nokia Corp. (NYSE:NOK): Current price $6.64

During the process in which Nokia is divesting its handset business to Microsoft, the Financial Times reports that it will offer one year of free Netflix to customers who buy its devices on Vodafone. In September, Nokia announced that it was selling its handset business to Microsoft for $7.2 billion, but until is finalized, the firm wants to optimize what it may of that unit. The FT says that Nokia will be paying the bill for the majority of this giveaway but Netflix has been pushing assertively to move into Europe, and so probably would be willing to cover a part of the bill.


Micron Technology Inc. (NASDAQ:MU): Current price $17.09

Micron has seen analyst ratings come in mainly positive, as Jeffries, Bernstein Research, and TheStreet have raised targets while Wells Fargo downgraded. Analyst Sundeep Bajikar at Jeffries & Co maintained a Buy and updated the price target from $25 to $30, from his belief that the maturing DRAM manufacturing industry is becoming more stable. Analyst Mark Newman at Bernstein Research reaffirmed his Outperform, revising his price target sharply upwards to $24 from $4. Newman points to recovering dynamic random-access memory output and Micron’s acquisition of Elpida as reasons for his positive outlook.

However, Wells Fargo downgraded the stock to Underperform from Market Perform, saying that a volatile past and high-risk future do not make an attractive asset. Analyst David Wong referred to risks including unstable pricing for DRAM and NAND chips and the firm’s unreliable profitability. In face of the downgrade, Wells Fargo revised his price target to $14 to $17 from $11 to $14.


ARIAD Pharmaceuticals Inc. (NASDAQ:ARIA): Current price $4.25

Levi & Korsinsky says that a class action lawsuit has been brought in the United States District Court for the District of Massachusetts on behalf of investors who acquired ARIAD stock between December 12, 2011 and October 8, 2013. The complaint claims that throughout the Class Period, defendants made false and misleading statements concerning the safety and efficacy of the leukemia drug Iclusig.


Don’t Miss: Microsoft Updates Windows for New Nokia Devices.